JP MORGAN/CALL/MEDTRONIC/80/0.1/19.07.24 Share Price

Warrant

DE000JK54368

Market Closed - Börse Stuttgart 12:13:05 05/07/2024 pm IST
0.03 EUR +20.00% Intraday chart for JP MORGAN/CALL/MEDTRONIC/80/0.1/19.07.24
Current month-62.96%
1 month-92.50%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
05/24/05 0.03 +20.00%
04/24/04 0.025 -19.35%
03/24/03 0.031 +3.33%
02/24/02 0.03 -64.29%
01/24/01 0.084 +3.70%

Delayed Quote Börse Stuttgart

Last update July 05, 2024 at 12:13 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MEDTRONIC PLC
Issuer J.P. Morgan
WKN JK5436
ISINDE000JK54368
Date issued 16/04/2024
Strike 80 $
Maturity 19/07/2024 (12 Days)
Parity 10 : 1
Emission price 0.4
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.65
Lowest since issue 0.025
Spread 0.01
Spread %24.39%

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
77.61 USD
Average target price
94.02 USD
Spread / Average Target
+21.15%
Consensus